Silverarc Capital Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $11.7M | Buy |
|
|||||
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $7.18M | Sell |
|
|||||
|
2024
Q3 | $13.2M | Buy |
|
|||||
|
2024
Q2 | $10.2M | Buy |
|
|||||
|
2024
Q1 | $6.97M | Buy |
|
|||||
|
2023
Q4 | $5.68M | Buy |
|
|||||
|
2023
Q3 | $6.35M | Buy |
|
|||||
|
2023
Q2 | $7.34M | Buy |
|
|||||
|
2023
Q1 | $6.25M | Buy |
|
|||||
|
2022
Q4 | $2.07M | Sell |
|
|||||
|
2022
Q3 | $9.05M | Sell |
|
|||||
|
2022
Q2 | $7.41M | Buy |
|
|||||
|
2022
Q1 | $4.3K | Sell |
|
|||||
|
2021
Q4 | $7.3M | Buy |
|
|||||
|
2021
Q3 | $5.7M | Buy |
|
|||||
|
2021
Q2 | $1.61K | Buy |
|
|||||
|
2021
Q1 | $1.05M | Sell |
|
|||||
|
2020
Q4 | $2.64M | Buy |
|